In brief: A new sleeping pill
In Brief
A new sleeping pill
The most widely used prescription sleeping pills are benzodiazepines, including lorazepam (Ativan) and the related drugs zolpidem (Ambien) and eszopiclone (Lunesta). Some physicians and patients also favor antidepressants, especially trazodone (Desyrel). Benzodiazepine receptor agonists increase the activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is found throughout the brain. Antidepressants influence the neurotransmitters norepinephrine and serotonin, which also have pervasive effects on the brain.
Ramelteon (Rozerem), approved in 2005 by the FDA, is a new kind of sleeping pill, more selective in its effects and — the hope is — safer. Whether it will prove to be as effective is still uncertain. It acts at receptors for the hormone melatonin, which helps to regulate the body's circadian (24-hour) rhythms, including the cycle of sleep and waking.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.